NON PROPIETRY, THEREFORE N/A ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
51Scleroderma1

51. Scleroderma


Clinical trials : 523 Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002799-41-GB
(EUCTR)
15/08/200729/06/2005Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemiaIontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemia Digital ischaemia/ulceration in patients with scleroderma-spectrum disordersTrade Name: NON PROPIETRY, THEREFORE N/A
Product Name: SODIUM NITROPRUSSIDE
Salford Royal Hospitals TrustUNIVERSITY OF MANCHESTERNot RecruitingFemale: yes
Male: yes
6Phase 2United Kingdom